Histocompatibility antigen (HLA) associations with multiple sclerosis in Iran

Multiple Sclerosis

Volumn 6, Issue 5, 2000, Pages 317-319

  Kalanie, H ^a   Kamgooyan, M ^b   Sadeghian, H ^a   Kalanie, A R ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IRANIAN BLOOD TRANSFUSION ORGANIZATION   (Iran)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

HLA; Iran; Multiple sclerosis

Indexed keywords

HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA A3 ANTIGEN; HLA ANTIGEN; HLA B7 ANTIGEN; HLA B8 ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR2 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; PREVALENCE; RELAPSE; TISSUE TYPING;

ADOLESCENT; ADULT; AGE OF ONSET; B-LYMPHOCYTES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HLA-A ANTIGENS; HLA-DR ANTIGENS; HLA-DR2 ANTIGEN; HUMANS; IRAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING;

EID: 0033760199     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/135245850000600504     Document Type: Article

References (21)

1. Epidemiology of multiple sclerosis
2. HLA patterns in multiple sclerosis
3. Different B lymphocyte alloantigens associated with multiple sclerosis in Arabs and Northern Europeans
4. HLA-DQB1 genotype in Sardinian multiple sclerosis: Evidence for a key role of DQB1.0201 and DQB1.0302 alleles
5. DRB1-DQA1-DQB1 Loci and multiple sclerosis predisposition in the Sardinian population
6. Genetics of multiple sclerosis
7. New diagnostic criteria for multiple sclerosis: Guide lines for research protocols
8. Assessment of MRI criteria for a diagnosis of MS
9. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
10. Histocompatibility antigens in multiple sclerosis patients participating in a multicentre trial of azathioprine
11. The distribution of class I and class II HLA antigens in an Iranian population using the 3rd A.O.H.W.C. Antisera
12. The association of HLA DR2 in caucasian multiple sclerosis patients in Buenos Aires, Argentina
13. HLA DR15. Outcome and susceptibility in multiple sclerosis
14. HLA antigens of multiple sclerosis patients in Istria, Western Croatia
15. Study of HLA as a predisposing factor and its possible influence on the outcome of multiple sclerosis in the sanitary district of Calatayud, northern Spain
16. Characteristic of histocompatibility antigens distribution in patients with multiple sclerosis
17. Molecular analysis of HLA class I (Hla-A and B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type)
18. Histocompatibility antigens (HLA) in multiple sclerosis in Iran
19. HLA-DR and -DQ associations with multiple sclerosis in Turkey
20. Class II HLA antigens in patients with multiple sclerosis from Warsaw and Gadansk regions